TWO SIGMA ADVISERS, LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 126 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$3,628,820
-31.1%
1,067,300
+48.9%
0.01%
-30.8%
Q2 2023$5,269,215
+4.0%
716,900
+46.6%
0.01%0.0%
Q1 2023$5,067,076
+84.2%
489,100
+110.0%
0.01%
+62.5%
Q4 2022$2,750,549
-44.6%
232,900
-1.6%
0.01%
-42.9%
Q3 2022$4,966,000
-34.1%
236,600
-2.6%
0.01%
-33.3%
Q2 2022$7,540,000
-31.2%
242,900
-9.0%
0.02%
-27.6%
Q1 2022$10,963,000
+75.4%
267,000
+85.7%
0.03%
+81.2%
Q4 2021$6,251,000
+2215.2%
143,800
+2563.0%
0.02%
+1500.0%
Q3 2021$270,000
-98.3%
5,400
-97.9%
0.00%
-97.6%
Q2 2021$15,999,000
+0.7%
254,000
+65.3%
0.04%
-6.7%
Q3 2020$15,882,000
+4958.0%
153,700
+2264.6%
0.04%
+4400.0%
Q2 2019$314,000
-15.8%
6,500
+3.2%
0.00%0.0%
Q4 2018$373,000
-65.9%
6,300
-62.0%
0.00%
-66.7%
Q3 2018$1,093,000
-49.9%
16,600
-61.6%
0.00%
-50.0%
Q2 2018$2,181,000
-24.0%
43,190
-20.7%
0.01%
-25.0%
Q1 2018$2,869,000
-4.3%
54,490
-15.5%
0.01%0.0%
Q4 2017$2,997,000
+34.3%
64,490
+16.9%
0.01%
+33.3%
Q3 2017$2,232,000
-12.0%
55,190
-26.2%
0.01%
-25.0%
Q2 2017$2,536,000
-9.0%
74,790
-22.1%
0.01%
-11.1%
Q1 2017$2,788,000
-37.1%
95,990
-28.8%
0.01%
-47.1%
Q4 2016$4,430,000
-12.2%
134,890
-15.7%
0.02%
-22.7%
Q3 2016$5,048,000
+24.3%
160,090
+10.9%
0.02%
+4.8%
Q2 2016$4,060,000
-10.9%
144,390
+15.2%
0.02%
-19.2%
Q1 2016$4,558,000
-17.5%
125,390
-9.2%
0.03%
-21.2%
Q4 2015$5,525,000
+49.6%
138,090
+7.5%
0.03%
+43.5%
Q3 2015$3,694,000
-19.0%
128,490
-7.2%
0.02%
-34.3%
Q2 2015$4,560,000
+12.1%
138,390
-2.2%
0.04%
+12.9%
Q1 2015$4,069,000
+43.3%
141,490
+35.7%
0.03%
+34.8%
Q4 2014$2,840,000
+32.8%
104,290
+3.9%
0.02%
+35.3%
Q3 2014$2,139,000
-12.6%
100,390
-7.8%
0.02%
-10.5%
Q2 2014$2,446,000
-51.2%
108,890
-45.1%
0.02%
-58.7%
Q1 2014$5,016,000
+195.2%
198,490
+168.6%
0.05%
+187.5%
Q4 2013$1,699,000
+42.8%
73,890
+18.2%
0.02%
+14.3%
Q3 2013$1,190,000
+54.7%
62,490
+17.2%
0.01%
+27.3%
Q2 2013$769,00053,3400.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders